Optic nerve sheath meningiomas

Ophthalmology

Volumn 110, Issue 10, 2003, Pages 2019-2030

  Saeed, Peerooz ^a,b   Rootman, Jack ^a   Nugent, Robert A ^a   White, Valerie A ^a   Mackenzie, Ian R ^a   Koornneef, Leo ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALCIFICATION; CASE STUDY; CELL TYPE; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; OPTIC NERVE SHEATH MENINGIOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR LOCALIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0141858766     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(03)00787-5     Document Type: Article

References (50)

1. Alper MG. Management of primary optic nerve meningiomas. Current status-therapy in controversy. J Clin Neuroophthalmol 1981;1(2):101-17.
2. Clark WC, Theofilos CS, Fleming JC. Primary optic nerve sheath meningiomas. Report of nine cases. J Neurosurg 1989; 70:37-40.
3. Egan RA, Lessell S. A contribution to the natural history of optic nerve sheath meningiomas. Arch Ophthalmol 2002;120: 1505-8.
4. Ito M, Ishizawa A, Miyaoko M, et al. Intraorbital meningiomas. Surgical management and role of radiation therapy. Surg Neurol 1988;29:448-53.
5. Kennerdell JS, Maroon JC, Malton M, Warren FA. The management of optic nerve sheath meningiomas. Am J Ophthalmol 1988;106:450-7.
6. Miller NR. The evolving management of optic nerve sheath meningiomas [editorial]. Br J Ophthalmol 2002;86:1198.
7. Rose GE. Orbital meningiomas: surgery, radiotherapy, or hormones? Br J Ophthalmol 1993;77:313-4.
8. Samples JR, Robertson DM, Taylor JZ, Waller RR. Optic nerve meningioma. Ophthalmology 1983;90:1591-4.
9. Sibony PA, Krauss HR, Kennerdell JS, et al. Optic nerve sheath meningiomas: clinical manifestations. Ophthalmology 1984;91:1313-26.
10. Wilson WB. Meningiomas of the anterior visual system. Surv Ophthalmol 1981;26(3):109-27.
11. Wright JE. Primary optic nerve meningiomas: clinical presentation and management. Trans Am Acad Ophthalmol Otolaryngol 1977;83:617-25.
12. Wright JE, Call NB, Liaricos S. Primary optic nerve meningioma. Br J Ophthalmol 1980;64:553-8.
13. Wright JE, McNab AA, McDonald WI. Primary optic nerve sheath meningioma. Br J Ophthalmol 1989;73:960-6.
14. Dutton JJ. Optic nerve sheath meningiomas. Surv Ophthalmol 1992;37:167-83.
15. Rootman J, Stewart B, Goldberg RA. Orbital Surgery: A Conceptual Approach. Philadelphia: Lippincott-Raven; 1995.
16. Jakobiec FA, Depot MJ, Kennerdell JS, et al. Combined clinical and computed tomographic diagnosis of orbital glioma and meningioma. Ophthalmology 1984;91:137-55.
17. Abramovich CM, Prayson RA. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas. Arch Pathol Lab Med 1999;123:793-800.
18. Rohringer M, Sutherland GR, Louw DF, Sima AA. Incidence and clinicopathological features of meningioma. J Neurosurg 1989;71:665-72.
19. Scheithauer BW. Tumors of the meninges: proposed modifications of the World Health Organization classification. Acta Neuropathol (Berl) 1990;80:343-54.
20. Ohta M, Iwaki T, Kitamoto T, et al. MIB1 staining index and scoring of histologic features in meningioma: indicators for the prediction of biologic potential and postoperative management. Cancer 1994;74:3176-89.
21. Perry A, Scheithauer BW, Stafford SL, et al. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999;85:2046-56.
22. Graham DI, Lantos PL, eds. Greenfield's Neuropathology. Vol. 2. 6th ed. London: Arnold; 1997:727-52.
23. Burger PC, Scheithauer BW. Atlas of Tumor Pathology. Tumors of the Central Nervous System. 3rd ser, fasc 10. Washington: Armed Forces Institute of Pathology; 1994.
24. Hooper R. Intracranial tumours in childhood. Childs Brain 1975;1(2-3):136-40.
25. Gabibov GA, Blinkov SM, Tcherekayev VA. The management of optic nerve meningiomas and gliomas. J Neurosurg 1988;68:889-93.
26. Domenicucci M, Santoro A, D'Osvaldo DH, et al. Multiple intracranial meningiomas. J Neurosurg 1989;70:41-4.
27. Bloomgarden GM, Byrne TN, Spencer DD, Heafner MD. Meningioma associated with aneurysm and subarachnoid hemorrhage: case report and review of the literature. Neurosurgery 1987;20:24-6.
28. Ziyal IM, Aydin Y, Bejjani GK, et al. Multiple meningiomas and intracranial aneurysms: a case report and review of the literature. Acta Neurol Belg 1998;98:221-3.
29. Rootman J. Diseases of the Orbit: A Multidisciplinary Approach. Philadelphia: JB Lippincott; 1988:281-5.
30. Marquardt MD, Zimmerman LE. Histopathology of meningiomas and gliomas of the optic nerve. Hum Pathol 1982;13: 226-35.
31. Nakasu S, Nakasu Y, Nakajima M, et al. Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 1999;90:455-62.
32. Mark LE, Kennerdell JS, Maroon JC, et al. Microsurgical removal of a primary intraorbital meningioma. Am J Ophthalmol 1978;86:704-9.
33. Smith JL, Vuksanovic MM, Yates BM, Bienfang DC. Radiation therapy for primary optic nerve meningiomas. J Clin Neuroophthalmol 1981;1(2):85-99.
34. Lee AG, Woo SY, Miller NR, et al. Improvement in visual function in an eye with a presumed optic nerve sheath meningioma after treatment with three-dimensional conformal radiation therapy. J Neuroophthalmol 1996;16:247-51.
35. Moyer PD, Golnik KC, Breneman J. Treatment of optic nerve sheath meningioma with three-dimensional conformal radiation. Am J Ophthalmol 2000;129:694-6.
36. Pitz S, Becker G, Schiefer U, et al. Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol 2002;86:1265-8.
37. Black PM. Meningiomas. Neurosurgery 1993;32:643-57.
38. Kupersmith MJ, Warren FA, Newall J, Ransohoff J. Irradiation of meningiomas of the intracranial anterior visual pathway. Ann Neurol 1987;21:131-7.
39. Newman SA. Meningiomas: a quest for the optimum therapy. J Neurosurg 1994;80:191-4.
40. Peele KA, Kennerdell JS, Maroon JC, et al. The role of postoperative irradiation in the management of sphenoid wing meningiomas: a preliminary report. Ophthalmology 1996;103: 1761-6, discussion 1766-7.
41. Foote KD, Friedman WA, Buatti JM, et al. Linear accelerator radiosurgery in brain tumor management. Neurosurg Clin N Am 1999;10:203-42.
42. Turbin RE, Thompson CR, Kennerdell JS, et al. A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology 2002;109: 890-9, discussion 899-900.
43. Blankenstein MA, van der Meulen-Dijk C, Thijssen JH. Effect of steroids and antisteroids on human meningioma cells in primary culture. J Ster Biochem 1989;34:419-21.
44. Grunberg SM. Role of antiprogestational therapy for meningiomas. Hum Reprod 1994;9(suppl 1):202-7.
45. Hultberg BM, Haselbacher G, Nielsen FC, et al. Gene expression of insulin-like growth factor II in human intracranial meningioma. Cancer 1993;72:3282-6.
46. Koper JW, Zwarthoff EC, Hagemeijer A, et al. Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha. Eur J Cancer 1991;27:416-9.
47. Koper JW, Lamberts SW. Meningiomas, epidermal growth factor and progesterone. Hum Reprod 1994;9(suppl 1):190-4.
48. Lamberts SW, Tanghe HL, Avezaat C, et al. Mifepristone (RU 486) treatment of meningiomas. J Neurol Neurosurg Psychiatry 1992;55:486-90.
49. Reubi JC, Horisberger U, Lang W, et al. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors. Am J Pathol 1989;134:337-44.
50. Reubi JC, Maurer R, von Werder K, et al. Somatostatin receptors in human endocrine tumors. Cancer Res 1987;47: 551-8.